Statin Therapy

In statin-treated patients with dyslipidemia, the combination of obicetrapib and ezetimibe further lowered LDL, according to the results of the phase 2 ROSE2 trial.

Lipid panels, not statin prescription alone, should be reconsidered as a quality and performance measure of LDL control, according to a joint perspective from the National Lipid Association and American Society for Preventive Cardiology.

In this Healio | Cardiology Today video exclusive, Daniel Soffer, MD, FNLA, discussed some of the highlights so far from the National Lipid Association Scientific Sessions.

Properly managing cardiovascular disease in patients with immune-mediated inflammatory diseases requires following guidelines and inter-specialty collaboration, according to a speaker at the Biologic Therapies Summit.

Comparing a treat-to-target statin strategy with a high-intensity strategy for people with CAD.

Healio and Cardiology Today have compiled the top cardiology headlines of April 2023.

Statin-loading therapy at 12 and 2 hours before CABG — although safe and well tolerated — demonstrated no significant clinical benefit compared with placebo, researchers reported.

More than 10,000 discussions on the large social media platform Reddit showed mostly neutral feelings toward statins, with a smaller yet significant proportion showing negative sentiment, an artificial intelligence analysis showed.

Compared with men, women with atherosclerotic CVD were less likely to be prescribed any statin, less likely to be prescribed a high-intensity statin and more likely to be deemed statin-intolerant, electronic health records data show.

Statin therapy may improve risk for stroke or transient ischemic attack among patients with atrial fibrillation compared with nonuse, regardless of concomitant anticoagulant use, a speaker reported.